Brain cancer needs a national plan
Brain cancer needs a national plan
Mainul Haque

Brain cancer needs a national plan

Brain cancer survival remains poor and the burden on families is immense. Australia needs a coordinated 10-year national plan linking research, treatment, care and support.

On 14 October 2026, around 400 people gathered at Parliament House in Canberra for Brain Tumour Alliance Australia’s (BTAA) Head to the Hill event. One thousand pairs of shoes represented lives affected by brain cancer, while more than 300 personal stories gave a human voice to the numbers. Around 70 advocates met parliamentarians to call for greater attention to a disease that continues to devastate Australians and their families.

As a BTAA board member, I attended the event and was struck by the determination of those sharing their experiences. Yet I was also conscious of the gap between the strength of their voices and the national policy response they are seeking.

One conversation has stayed with me. I met a mother from Perth whose eight-year-old son died just 18 days after diagnosis, three days before his birthday. No statistic can convey what a family experiences in such circumstances. Behind every diagnosis is a person, a family and a future suddenly thrown into uncertainty.

The thousand pairs of shoes reminded me that brain cancer is not simply a medical issue. It is a family issue, a social issue and a national policy challenge.

The latest Australian Brain Cancer Landscape 2026, published by BTAA, highlights the scale of the challenge. Five-year survival for brain cancer is around 24 per cent, compared with 72 per cent across all cancers. BTAA’s material also estimates that only 3.6 per cent of Australians living after a brain cancer diagnosis are living beyond cancer.

These figures deserve serious attention. They highlight the stark gap in outcomes and the need for sustained progress in research, treatment and support.

Australia recorded around 2,000 brain cancer diagnoses and 1,580 deaths in 2023. Although brain cancer affects fewer people than some common cancers, its consequences can be devastating. Patients may experience cognitive changes, disability and loss of independence. Families often face difficult treatment decisions while trying to maintain employment, manage household finances and care for children or other dependants.

The challenge is expected to grow. BTAA’s published projections indicate that by 2050, more than 23,000 Australians could be living with brain cancer, with approximately 3,200 new diagnoses and 2,650 deaths annually. The estimated annual societal cost could rise from $850 million in 2025 to $3.2 billion by 2050 if current trends continue.

These estimates cannot capture the grief of losing a child or the strain on a family caring for someone with a life-threatening illness. BTAA estimates that informal care required around 3.7 million hours in 2025. This unpaid contribution shows that the true cost extends well beyond hospital budgets.

This is not about pitting one cancer against another. Every patient deserves appropriate care, and research investment should reflect evidence and need. But lower incidence should not mean lower priority when survival remains poor and the consequences for families are so severe.

BTAA’s 2026 Landscape report identifies priorities across research, clinical care and support services. These include a national brain cancer roadmap, stronger research investment, improved access to treatments and clinical trials, specialist care coordination and better support for patients and carers.

BTAA identifies $200 million over 10 years as the research investment it considers necessary. It also calls for $8.75 million to support 23 specialist care coordinators and funding to sustain a specialist national advocacy service.

Other priorities include better access to cancer navigation support, addressing barriers to disability and aged care services, and strengthening the Australian Brain Cancer Registry.

These proposals are connected. Research cannot deliver its full benefit if patients cannot access appropriate trials and treatments. Clinical care is harder to navigate when families lack specialist guidance. Patients also need support beyond the hospital, particularly when a diagnosis affects their ability to work, care for children or manage everyday life.

In my view, Australia needs a coordinated, long-term national response. I call on the Australian Government to lead the development of a 10-year national plan for brain tumours and brain cancer.

The plan should establish measurable goals for research, clinical care, access to treatments and trials, specialist nursing, care coordination and support for patients, families and carers. It should address gaps in disability and aged care, strengthen national data collection and report transparently on progress.

A national plan would connect research with clinical practice, improve equitable access to care and reduce the burden on families navigating complex services. It would also allow governments and the public to assess whether investment is improving outcomes.

Government must lead, but it need not act alone. Corporate Australia and the philanthropic sector, including major businesses, foundations and institutions, should contribute funding, expertise and research partnerships. These contributions should complement, not replace, the government’s responsibility to lead and fund a coordinated response.

People living with brain cancer, bereaved families, carers, clinicians and researchers must help shape the plan from the outset. Their experiences should inform policy design, not simply be heard at public events.

Accountability matters too. Australians should be able to see what has been funded, what progress has been made and where gaps remain. A 10-year commitment must be more than a statement of good intentions. It must provide a durable framework for action and evaluation.

Head to the Hill 2026 demonstrated the determination of people who refuse to let brain cancer remain outside the national conversation. The challenge now is to turn those stories into lasting policy change.

The mother I met from Perth should not have to rely on public attention alone to make her son’s story count. Her experience, and those of thousands of other families, should help shape a stronger national response.

A national plan cannot promise a cure or remove the grief brain cancer brings. But Australia can choose to invest in research, improve access to care, support families and hold itself accountable for progress.

It is time to put our shoulder to the wheel. The Australian Government must lead, with corporate Australia, philanthropy, researchers, health professionals and communities helping turn that leadership into action.

People affected by brain cancer have made their case. The evidence is confronting, the needs are clear and the opportunity to make a difference is before us. Australia now needs a national commitment equal to the challenge.

 

*Mainul Haque OAM is an economist, former ACT Multicultural Ambassador and board member of Brain Tumour Alliance Australia.


The views expressed in this article may or may not reflect those of Pearls and Irritations.

Mainul Haque